"10.1371_journal.pone.0098202","plos one","2014-05-30T00:00:00Z","Motomu Hashimoto; Takao Fujii; Masahide Hamaguchi; Moritoshi Furu; Hiromu Ito; Chikashi Terao; Keiichi Yamamoto; Wataru Yamamoto; Takashi Matsuo; Masato Mori; Koichiro Ohmura; Hiroshi Kawabata; Tsuneyo Mimori","Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan","Conceived and designed the experiments: M. Hashimoto TF T. Mimori. Performed the experiments: M. Hashimoto TF MF HI KO. Analyzed the data: M. Hashimoto M. Hamaguchi CT. Contributed reagents/materials/analysis tools: KY WY T. Matsuo MM. Wrote the paper: M. Hashimoto M. Hamaguchi HK.","The authors have read the journals policy and have the following conflicts: M. Hashimoto, T.F., M.F., H.I., and T. Mimori are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co., Ltd., AbbVie GK., Eisai Co., Ltd.). M.H. and M.F. has received grant and research support from Astellas Pharma Inc. and Pfizer Japan Inc. H.I. has received grant and research support from Astellas Pharma Inc., Pfizer Japan Inc., NTT communications, and Takeda Pharmaceutical Co., Ltd. T.F. has received grant and research support from Takeda Pharmaceutical Co., Santen Pharmaceutical Co., Ltd., Astellas Pharma Inc., Asahi Kasei Pharma Corporation, and Daiichi Sankyo Co., Ltd.  T.M. has received grant and research support from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Santen Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and speakers bureau from AbbVie GK., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. K.O. has received grant and research support from AbbVie GK., Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and speakers bureau from AbbVie GK., Astellas Pharma, Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that although they are affiliated with a department that is supported financially by pharmaceutical companies, the authors received no current funding for this study and this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2014","05","Motomu Hashimoto","MH",13,TRUE,1,1,1,1,TRUE,TRUE,TRUE,3,"5;11;12",TRUE
